semaglutide aka What is Semaglutide? Ozempic Semaglutide for the People |

A one-size-fits-all cutoff can miss the patients at the highest metabolic risk

Omega-3 fatty acids

Retatrutide improves it through GLP-1 and GIP signaling at the pancreas

To view or add a comment, sign in A new milestone for diabetes care! Oral semaglutide just earned FDA approval for reducing cardiovascular risks in high-risk type 2 diabetes patients a major step forward in cardiometabolic health. Read More: #FDAApproval #DiabetesCare #Semaglutide #PharmaNews #HealthcareInnovation #OneAlphaMed FDA Clears Oral Semaglutide for Heart Protection in Diabetes! A landmark approval! The FDA has officially approved oral semaglutide to reduce cardiovascular events in high-risk type 2 diabetes patients reinforcing its dual impact on metabolic control and heart health

For years, clinicians have struggled to counteract these metabolic side effects with lifestyle programs or add-on prescriptions, but the results (so far) have underwhelmed mental health professionals